Koninklijke Philips Operating Margin 2012-2025 | PHG
Current and historical operating margin for Koninklijke Philips (PHG) over the last 10 years. The current operating profit margin for Koninklijke Philips as of September 30, 2025 is 7.66%.
| Koninklijke Philips Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $19.08B | $1.38B | 7.21% |
| 2025-06-30 | $18.86B | $1.87B | 9.91% |
| 2025-03-31 | $18.81B | $1.66B | 8.80% |
| 2024-09-30 | $18.97B | $0.87B | 4.57% |
| 2024-06-30 | $18.60B | $0.51B | 2.73% |
| 2023-06-30 | $18.89B | $-0.27B | -1.43% |
| 2023-03-31 | $18.85B | $-0.26B | -1.38% |
| 2022-06-30 | $19.63B | $0.76B | 3.86% |
| 2021-06-30 | $20.30B | $1.10B | 5.42% |
| 2020-06-30 | $19.93B | $1.28B | 6.41% |
| 2019-06-30 | $22.93B | $1.93B | 8.40% |
| 2018-06-30 | $24.26B | $2.07B | 8.54% |
| 2017-06-30 | $25.77B | $2.14B | 8.31% |
| 2016-12-31 | $27.13B | $2.08B | 7.68% |
| 2016-09-30 | $27.08B | $1.36B | 5.02% |
| 2016-06-30 | $26.99B | $1.20B | 4.46% |
| 2016-03-31 | $26.98B | $1.17B | 4.32% |
| 2015-12-31 | $26.92B | $1.10B | 4.09% |
| 2015-09-30 | $26.06B | $0.93B | 3.55% |
| 2015-06-30 | $26.93B | $0.42B | 1.57% |
| 2015-03-31 | $27.58B | $0.49B | 1.79% |
| 2014-12-31 | $28.44B | $0.65B | 2.27% |
| 2014-09-30 | $30.72B | $1.61B | 5.23% |
| 2014-06-30 | $30.80B | $2.34B | 7.60% |
| 2014-03-31 | $30.92B | $2.55B | 8.25% |
| 2013-12-31 | $30.99B | $2.65B | 8.54% |
| 2013-09-30 | $31.41B | $1.78B | 5.66% |
| 2013-06-30 | $31.96B | $1.91B | 5.97% |
| 2013-03-31 | $31.77B | $1.45B | 4.56% |
| 2012-12-31 | $32.19B | $1.63B | 5.07% |
| 2012-09-30 | $31.35B | $1.50B | 4.78% |
| 2012-06-30 | $30.80B | $0.95B | 3.10% |
| 2012-03-31 | $31.11B | $1.08B | 3.48% |
| 2011-12-31 | $31.33B | $1.33B | 4.24% |
| 2011-09-30 | $32.59B | $2.35B | 7.21% |
| 2011-06-30 | $33.09B | $2.78B | 8.41% |
| 2011-03-31 | $33.49B | $2.97B | 8.85% |
| 2010-12-31 | $33.77B | $2.66B | 7.87% |
| 2010-09-30 | $34.44B | $3.94B | 11.44% |
| 2010-06-30 | $34.60B | $3.71B | 10.73% |
| 2010-03-31 | $34.14B | $2.13B | 6.23% |
| 2009-12-31 | $32.91B | $1.35B | 4.10% |
| 2009-09-30 | $32.42B | $-0.97B | -2.98% |
| 2009-06-30 | $33.85B | $-1.42B | -4.20% |
| 2009-03-31 | $36.52B | $-0.01B | -0.02% |
| 2008-12-31 | $38.81B | $0.52B | 1.35% |
| 2008-09-30 | $40.05B | $1.46B | 3.66% |
| 2008-06-30 | $39.47B | $1.99B | 5.05% |
| 2008-03-31 | $37.59B | $2.07B | 5.50% |
| 2007-12-31 | $36.50B | $2.11B | 5.78% |
| 2007-09-30 | $35.52B | $4.74B | 13.35% |
| 2007-06-30 | $34.61B | $4.28B | 12.35% |
| 2007-03-31 | $35.94B | $4.28B | 11.91% |
| 2006-12-31 | $36.96B | $4.27B | 11.55% |
| 2006-09-30 | $37.80B | $1.85B | 4.89% |
| 2006-06-30 | $39.05B | $2.33B | 5.96% |
| 2006-03-31 | $39.12B | $2.71B | 6.93% |
| 2005-12-31 | $38.95B | $2.77B | 7.11% |
| 2005-09-30 | $44.75B | $5.05B | 11.29% |
| 2005-06-30 | $44.29B | $4.95B | 11.17% |
| 2005-03-31 | $43.45B | $4.50B | 10.36% |
| 2004-12-31 | $43.03B | $4.40B | 10.22% |
| 2004-09-30 | $36.64B | $-1.59B | -4.34% |
| 2004-06-30 | $35.68B | $-1.90B | -5.33% |
| 2004-03-31 | $34.33B | $-2.31B | -6.74% |
| 2003-12-31 | $33.02B | $-2.56B | -7.75% |
| 2003-09-30 | $31.21B | $-2.37B | -7.58% |
| 2003-06-30 | $30.53B | $-2.37B | -7.76% |
| 2003-03-31 | $30.46B | $-2.77B | -9.10% |
| 2002-12-31 | $30.11B | $-2.78B | -9.23% |
| 2002-09-30 | $29.48B | $-20.82B | -70.63% |
| 2002-06-30 | $28.64B | $-14.67B | -51.23% |
| 2002-03-31 | $27.92B | $-7.65B | -27.39% |
| 2001-12-31 | $28.84B | $-0.19B | -0.64% |
| 2001-09-30 | $30.28B | $-2.65B | -8.74% |
| 2001-06-30 | $32.42B | $-0.37B | -1.15% |
| 2001-03-31 | $34.35B | $1.62B | 4.71% |
| 2000-12-31 | $35.03B | $2.38B | 6.78% |
| 2000-09-30 | $35.19B | $4.84B | 13.75% |
| 2000-06-30 | $34.86B | $4.51B | 12.94% |
| 2000-03-31 | $33.97B | $3.61B | 10.64% |
| 1999-12-31 | $33.40B | $3.05B | 9.12% |
| 1999-09-30 | $31.72B | $31.72B | 100.00% |
| 1999-06-30 | $31.79B | $31.79B | 100.00% |
| 1999-03-31 | $32.99B | $32.99B | 100.00% |
| 1998-12-31 | $33.89B | $33.89B | 100.00% |
| 1998-09-30 | $37.85B | $37.85B | 100.00% |
| 1998-06-30 | $38.92B | $38.92B | 100.00% |
| 1998-03-31 | $39.01B | $39.01B | 100.00% |
| 1997-12-31 | $39.13B | $39.13B | 100.00% |
| 1997-09-30 | $39.39B | $39.39B | 100.00% |
| 1997-06-30 | $39.63B | $39.63B | 100.00% |
| 1997-03-31 | $40.14B | $40.14B | 100.00% |
| 1996-12-31 | $40.97B | $40.97B | 100.00% |
| 1996-06-30 | $28.53B | $28.53B | 100.00% |
| 1996-03-31 | $28.47B | $28.47B | 100.00% |
| 1995-09-30 | $38.67B | $38.67B | 100.00% |
| 1995-06-30 | $37.11B | $37.11B | 100.00% |
| 1995-03-31 | $35.48B | $35.48B | 100.00% |
| 1994-12-31 | $33.79B | $33.79B | 100.00% |
| 1994-06-30 | $22.52B | $22.52B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $28.127B | $19.503B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.934B | 24.19 |
| EssilorLuxottica (ESLOY) | France | $146.214B | 0.00 |
| Stryker (SYK) | United States | $138.797B | 27.56 |
| Boston Scientific (BSX) | United States | $135.955B | 31.09 |
| Medtronic (MDT) | Ireland | $128.573B | 17.81 |
| Medline (MDLN) | United States | $56.884B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.666B | 0.00 |
| Agilent Technologies (A) | United States | $39.625B | 25.05 |
| ResMed (RMD) | United States | $37.840B | 26.19 |
| GE HealthCare Technologies (GEHC) | United States | $36.943B | 17.67 |
| Terumo (TRUMY) | Japan | $20.195B | 22.73 |
| Insulet (PODD) | United States | $20.046B | 62.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.153B | 10.70 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.928B | 0.00 |
| Baxter (BAX) | United States | $10.132B | 8.18 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.404B | 30.22 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.406B | 13.42 |
| Envista Holdings (NVST) | United States | $4.056B | 23.27 |
| BillionToOne (BLLN) | United States | $3.850B | 0.00 |
| ICU Medical (ICUI) | United States | $3.830B | 24.32 |
| Haemonetics (HAE) | United States | $3.282B | 14.61 |
| Prestige Consumer Healthcare (PBH) | United States | $3.222B | 14.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.147B | 47.00 |
| Perrigo (PRGO) | Ireland | $2.052B | 5.14 |
| QuidelOrtho (QDEL) | United States | $1.999B | 12.85 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| AtriCure (ATRC) | United States | $1.952B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.700B | 16.98 |
| Curaleaf Holdings (CURLF) | Canada | $1.649B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.608B | 70.46 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.431B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.425B | 20.63 |
| Kestra Medical Technologies (KMTS) | United States | $1.377B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.230B | 365.00 |
| Capricor Therapeutics (CAPR) | United States | $1.111B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.010B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.893B | 10.09 |
| Omeros (OMER) | United States | $0.856B | 0.00 |
| Valneva SE (VALN) | France | $0.854B | 0.00 |
| CeriBell (CBLL) | United States | $0.822B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 16.08 |
| Verano Holdings (VRNO) | United States | $0.494B | 0.00 |
| Cerus (CERS) | United States | $0.486B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Cresco Labs (CRLBF) | United States | $0.422B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.420B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Quanterix (QTRX) | United States | $0.329B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.285B | 22.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| Sanuwave Health (SNWV) | United States | $0.236B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.201B | 17.73 |
| OraSure Technologies (OSUR) | United States | $0.199B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Accendra Health (ACH) | United States | $0.166B | 1.66 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.156B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.84 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.105B | 4.58 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 26.15 |
| Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 35.08 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.19 |
| Bonk (BNKK) | United States | $0.025B | 0.00 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |